Leadership

Leadership

Our team is composed of experts with an unparalleled knowledge of science, technology, and medicine. Their depth of experience is unmatched in the quest to reduce the burden of infectious disease around the globe.

John C. Jacobs
John C. Jacobs
President and Chief Executive Officer
Rick Crowley
Rick Crowley
Executive Vice President,
Chief Operations Officer
Filip Dubovsky, MD MPH
Filip Dubovsky, MD MPH
President,
Research and Development
John A. Herrmann III
John A. Herrmann III
Executive Vice President,
Chief Legal Officer
Jill Hoyt
Jill Hoyt
Executive Vice President,
Chief Human Resources Officer
Jim Kelly
Jim Kelly
Executive Vice President,
Chief Financial Officer and
Treasurer
Troy Morgan, JD
Troy Morgan, JD
Senior Vice President,
Chief Compliance Officer
Elaine O’Hara
Elaine O’Hara
Executive Vice President,
Chief Strategy Officer
Silvia Taylor
Silvia Taylor
Executive Vice President,
Chief Corporate Affairs and Advocacy Officer
John J. Trizzino
John J. Trizzino
Executive Vice President,
Chief Commercial Officer and Chief Business Officer
Sven Andréasson
Sven Andréasson
Senior Vice President,
Corporate Development
Marco Cacciuttolo
Marco Cacciuttolo
Senior Vice President,
Process and Analytical Development
Frank Czworka
Frank Czworka
Senior Vice President,
Global Sales, Trade & Distribution
Timothy J. Hahn, PhD
Timothy J. Hahn, PhD
Senior Vice President,
Influenza CMC
Michael Kahsai, PhD
Michael Kahsai, PhD
Senior Vice President,
Quality Assurance and Quality Control
Denny Kim, MD, MPH
Denny Kim, MD, MPH
Senior Vice President,
Chief Safety Officer
Biegie Lee
Biegie Lee
Senior Vice President,
Chief Information Officer
Raburn Mallory, MD
Raburn Mallory, MD
Senior Vice President,
Clinical Development
Gale E. Smith, PhD
Gale E. Smith, PhD
Senior Vice President,
Discovery and Pre-clinical Research, Chief Scientist
Seth Toback, MD
Seth Toback, MD
Senior Vice President, Medical Affairs
Henrietta Ukwu, MD
Henrietta Ukwu, MD
Executive Vice President,
Chief Regulatory Officer
Robert Walker, MD
Robert Walker, MD
Senior Vice President,
Deputy Chief Medical Officer
Brian Webb
Brian Webb
Senior Vice President,
Global Manufacturing Operations
Russell P. "Rip" Wilson
Russell P. "Rip" Wilson
Executive Vice President
and General Manager, Influenza
John C. Jacobs
John C. Jacobs
President and Chief Executive Officer
James F. Young, PhD
James F. Young, PhD
Chairman of the
Board of Directors
Gregg Alton
Gregg Alton
Director
Richard Douglas, PhD
Richard Douglas, PhD
Director
Rachel King
Rachel King
Director
Margaret G. McGlynn, R. Ph.
Margaret G. McGlynn, R. Ph.
Director
David Mott
David Mott
Director
Rick Rodgers, MBA
Rick Rodgers, MBA
Director
Novavax’ Compliance program

Annual Declaration Clause for California (June 2023)

Novavax is committed to establishing and maintaining an effective compliance program that promotes conducting business activities in accordance with applicable laws, rules, and regulations, with the highest ethical standards in its interactions with all medical and health professionals and organizations. Novavax’ compliance program is designed to prevent, detect, and respond to potential instances of non-compliance.

Novavax Inc. declares that, to the best of our knowledge and understanding of statutory requirements, we have established a Comprehensive Compliance Program (CCP) that is in compliance with the Cal. Health & Safety Code §§ 119400-119402.

To obtain a written copy of our Code of Conduct or a written declaration of compliance, please contact 844-612-0252.

Careers

Build your future with us

Investors

Annual reports, events, and more

Science & Technology

Our pipeline—creating tomorrow's vaccine today